The quiet modulator that tunes mood, sleep, and the feeling of having had enough.
Overview
Serotonin (5-hydroxytryptamine, or 5-HT) is a monoamine neurotransmitter synthesized from the amino acid tryptophan. Though pop science casts it as the "happiness chemical," its real job is closer to a dimmer switch than a light: it modulates rather than commands. Serotonin shapes mood, regulates the sleep-wake cycle, governs appetite and satiety, and influences pain, aggression, and social behavior. It is also the raw material for melatonin, the hormone of darkness and sleep, which the pineal gland builds from serotonin as night falls, one reason mood and the sleep-wake cycle are so entwined. Strikingly, only about five percent of the body's serotonin lives in the brain; the overwhelming majority is produced in the gut, where it drives intestinal motility, one anchor of the gut-brain axis. In the brain proper, most serotonin originates in the raphe nuclei of the brainstem, a small set of clusters that project diffusely across nearly the whole cortex, a modest source with vast, tone-setting reach, much like the Norepinephrine system it works beside.
The Serotonin Hypothesis
The mid-century serotonin hypothesis of depression proposed that low serotonin causes low mood, the familiar "chemical imbalance" story. It was always an oversimplification, and recent umbrella reviews have found little direct evidence that depression stems from a serotonin deficit per se. Mood disorders are better understood as failures of neuroplasticity and network regulation, with serotonin as one input among many including Dopamine, stress hormones, inflammation, and circuit-level dysfunction. This is a case where the science is genuinely unsettled and worth holding honestly: the neat one-molecule story is discredited, but that does not mean serotonin is irrelevant, only that its role is subtler and more distributed than a simple thermostat of happiness.
SSRIs and the Nuance
SSRIs (selective serotonin reuptake inhibitors): fluoxetine, sertraline, escitalopram, work by blocking the reuptake transporter (SERT), the pump that normally clears serotonin from the synapse, leaving more of it in the cleft. Yet that effect is immediate while clinical benefit takes weeks, which is itself the strongest clue that the simple deficit model is wrong. The therapeutic action likely flows from downstream adaptations: gradual desensitization of inhibitory autoreceptors that lets serotonergic firing recover, increased BDNF (a growth factor that promotes Neuroplasticity), and slow remodeling of circuits, the same plasticity-driven change that likely underlies recovery from Depression more broadly. The drugs work for many people; the explanatory story we told about why is incomplete.
Psychedelics and Receptors
Serotonin acts through at least fourteen receptor subtypes, most of them metabotropic and slow-acting, which is much of why serotonin modulates rather than commands. The 5-HT2A receptor is the molecular gateway for classic psychedelics, psilocybin, LSD, DMT, whose agonism there produces altered perception and the consciousness-dissolving states studied in consciousness research. That same 5-HT2A agonism is now thought to drive the surge of cortical plasticity behind psychedelics' emerging therapeutic effects, and it quiets the Default Mode Network, the self-referential system whose loosening people describe as ego dissolution.
Related
- Dopamine, the partner monoamine in mood and motivation
- Norepinephrine, the fellow diffuse-projection modulator
- Neurotransmitters, the broader signaling family serotonin belongs to
- Neuroplasticity, the downstream remodeling SSRIs likely work through
- Default Mode Network, the self-system 5-HT2A agonism loosens
- The Brain, the organ this all happens inside
- Depression, the condition the serotonin story tried to explain